Sanofi

Sanofi and Regeneron's Dupixent shows more encouraging results
Sanofi and Regeneron's Dupixent shows more encouraging results
Reuters
Sanofi
Dupixent
atopic dermatitis
clinical trials
Flag link:
Sanofi CEO: Amid COVID-19 supply push, one fever means 'maybe a half dozen' workers off the job
Sanofi CEO: Amid COVID-19 supply push, one fever means 'maybe a half dozen' workers off the job
Fierce Pharma
Sanofi
COVID-19
Paul Hudson
Plaquenil
hydroxychloroquine
drug manufacturing
Flag link:
Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead
Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead
Fierce Pharma
vaccines
COVID-19
Sanofi
Pfizer
GSK
Moderna Therapeutics
Flag link:
Regeneron and Sanofi Treat First Person Outside U.S. in Coronavirus-Drug Trial
Regeneron and Sanofi Treat First Person Outside U.S. in Coronavirus-Drug Trial
TheStreet.com
Regeneron
Sanofi
clinical trials
COVID-19
Kevzara
Flag link:
Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio
Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio
Pharmaforum
Sanofi
Sanofi Pasteur
vaccines
Translate Bio
MRNA
COVID-19
Flag link:
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Flag link:
Go or no go? Covid-19 upstages US regulatory decisions
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
FDA
regulatory
Bristol-Myers Squibb
ozanimod
Esteve
E-58425
Fabre-Kramer
AstraZeneca
Imfinzi
Astellas
Vesicare
AbbVie
Neurocrine
Orlissa
Sanofi
MenQuadfi
opicapone
Acceleron
Reblozyl
Flag link:
Why Is Everyone Talking About Regeneron?
Why Is Everyone Talking About Regeneron?
Motley Fool
Regeneron
COVID-19
Google searches
Sanofi
Kevzara
Flag link:
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
Flag link:
Why Sanofi's Coronavirus Vaccine Work Hasn't Helped Its Stock
Why Sanofi's Coronavirus Vaccine Work Hasn't Helped Its Stock
Motley Fool
Sanofi
vaccines
coronaviruses
COVID-19
Flag link:
Sanofi joins parade of drugmakers pledging no COVID-19 shortages
Sanofi joins parade of drugmakers pledging no COVID-19 shortages
Fierce Pharma
drug shortages
Sanofi
China
COVID-19
Flag link:
Regeneron, Sanofi to iniate human trials of treatment for patients with severe COVID-19
Regeneron, Sanofi to iniate human trials of treatment for patients with severe COVID-19
Yahoo/Marketwatch
Regeneron
Sanofi
clinical trials
Kevzara
COVID-19
coronaviruses
Flag link:
Here's Why The Coronavirus Epidemic Could Boost Sanofi's Spinoff
Here's Why The Coronavirus Epidemic Could Boost Sanofi's Spinoff
Motley Fool
Sanofi
spinoffs
API manfacturing
APIs
coronaviruses
COVID-19
Flag link:
Could arthritis med Kevzara hold promise against the novel coronavirus? Sanofi, Regeneron aim to find out
Could arthritis med Kevzara hold promise against the novel coronavirus? Sanofi, Regeneron aim to find out
Fierce Pharma
Kevzara
Regeneron
Sanofi
COVID-19
coronaviruses
Flag link:
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Gilead Sciences
GSK
Innovio
JNJ
Moderna Therapeutics
Regeneron
Sanofi
Takeda
Vir Biotchnology
Flag link:
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Flag link:
More than half of its gross sales ultimately went to payers as rebates, Sanofi says
More than half of its gross sales ultimately went to payers as rebates, Sanofi says
Endpoints
Sanofi
drug pricing
rebates
Flag link:
FDA Greenlights Sanofi's Sarclisa for Multiple Myeloma
FDA Greenlights Sanofi's Sarclisa for Multiple Myeloma
BioSpace
FDA
Sarclisa
Sanofi
Multiple Myeloma
Flag link:
Sanofi, Justice Department ink $11.85M charity kickbacks settlement
Sanofi, Justice Department ink $11.85M charity kickbacks settlement
Fierce Pharma
Sanofi
kickbacks
charity
DOJ
Lemtrada
Flag link:
Ex-Sanofi chief Olivier Brandicourt, current Blackstone advisor, jumps on Alnylam board
Ex-Sanofi chief Olivier Brandicourt, current Blackstone advisor, jumps on Alnylam board
Endpoints
Sanofi
Olivier Brandicourt
Alnylam
Flag link:

Pages